Lanean...
Tolerability profile of bevacizumab in metastatic colorectal cancer: about a Medical Department experience
Colorectal cancer is one of the most common cancers worldwide, and associated with high mortality rates in our country. The prognosis of patients diagnosed with metastatic colorectal cancer (mCRC) has improved markedly over the last 12 years, increasing from 5 months with best supportive care to alm...
Gorde:
| Argitaratua izan da: | Pan Afr Med J |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The African Field Epidemiology Network
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5325501/ https://ncbi.nlm.nih.gov/pubmed/28292081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11604/pamj.2016.25.118.2266 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|